Tag Archives: pharmaceutical industry
Posted on 06. Jun, 2013 by RiffRaff.
The move towards targeted therapies is bringing fresh, and often unexpected, challenges to the pharmaceutical industry. In days gone by it was all about blockbuster drugs – those that generated more than $1 billion annually. The focus was on diseases with high prevalence, but that’s all changing. The patent cliff and shrinking drug pipelines have [...]
Posted on 06. Jun, 2013 by Theatre buff.
The UK’s NICE and SMC processes have traditionally been ranked among the toughest health technology assessment (HTA) processes to navigate access to new medicines, with the process often taking longer than in some other European countries. We take a look at the German and French systems to see how they are evolving to help check [...]
Posted on 07. Mar, 2013 by AnyNoise.
When you pick up a prescription, do you read that small folded leaflet on strange semi-see-through paper that comes inside the packet? No? Me neither, but obviously, you should. Those patient information leaflets (PILs) have been a legal requirement in the UK since 1999 and are seen as an integral part of ensuring patients take [...]
Posted on 07. Mar, 2013 by musicman.
From 1 April the structure in which the NHS buys services will change significantly. All players in the healthcare sector are fully aware of this milestone but many are still unsure about the level to which it will affect their business. For the pharmaceutical industry, it raises new challenges but also new opportunities. Unfortunately, getting [...]
Posted on 18. Feb, 2013 by cowsdrinkmilk.
Dr Ben Goldacre delivered a public lecture at the London School of Economics recently, after his recent and ongoing campaign coinciding with his book ‘Bad Pharma’, published primarily to expose ‘hidden clinical trial results’ within the pharmaceutical industry. It was a good opportunity to hear it directly from the horse’s mouth and identify how we, [...]
Working with the NHS is integral to the sustainability of pharmaceutical companies. But who is the NHS?
Posted on 05. Feb, 2013 by musicman.
I listened to an interesting webinar last week set up by PM Society. Dr Neil Fraser, Head of Long-Term Conditions at NHS Rushcliffe CCG and a GP in East Leake, Nottinghamshire and Kevin Blakemore, NHS Partnership Manager at ABPI, discussed joint working from both a NHS and pharma perspective and how they can best work [...]
Posted on 20. Dec, 2012 by musicman.
After months of toing and froing, creating new health organisations, shadow working and streamlining, the new commissioning model in the NHS will officially start from April 2013. Many will argue that it has already started, with new leaders in the NHS trying to stamp their authority as early as possible. The new commissioning structure will, [...]
Posted on 20. Dec, 2012 by Theatre buff.
The localism act received Royal Ascent in November 2011, devolving greater powers to councils and neighbourhoods and giving local communities more control over housing and planning decisions. But localism isn’t just a political phenomenon. The trend to valuing smaller, local activities versus those on a national or global scale is seen in many walks of [...]
Posted on 06. Apr, 2011 by neilcrump.
Friday last week saw the publication of the PMCPA informal guidance for use of digital channels. It is straightforward and neat guidance which makes it clear what we have always known: have a clear distinction between information and promotion, and ensure your intent is good. The guidance gets a KISS* from me. The pioneer [...]
Posted on 16. Feb, 2011 by balletfanatic.
This month’s issue of Pharmaceutical Marketing contains an article by Aurora that delves into the ‘upskilling’ argument about the pharmaceutical industry and social media. Aaron Pond, our digital lead, suggests that the issue is being ‘over cooked’ and focus should be placed on empowering internal teams, using new technologies smartly and ensuring that the social [...]
Posted on 29. Oct, 2010 by chiantichiara.
One accusation that is often levelled at my favourite football team is that they lack ‘bottle’. They don’t have the aggressive type of players who, when the chips are down, can take the game to the opposition and boss their way to victory. So where am I going with this? Well if you watched the [...]
Posted on 15. Jun, 2010 by NW1er.
The latest issue of Pharmaceutical Marketing (PM) is a social-media bumper-fest. Leading with an inspiring article from Alex Butler at Janssen-Cilag, it also features an enlightening piece from Terry Gault, a diabetes patient who actively engages with social media and discusses the value of community support. Aurora also features, discussing why those in our industry [...]
Posted on 29. Apr, 2010 by phaedrus.
On the 21st of April 2010, at Brown’s Courtroom in Covent Garden, Aurora played host to the first court case of its kind, placing health media materials in the dock, and asking a specialist jury of UK health journalists to reach a verdict. With Judge Jacqui Thornton presiding over the court, Daily Mail Medical Correspondent, [...]
Health media materials under the gavel tonight! 06.30 pm, Brown’s, St martin’s Lane. Follow events on Twitter!
Posted on 21. Apr, 2010 by NW1er.
The quality of health media materials provided to journalists are under the gavel in a court-room type drama at Brown’s Court Room tonight from 6.30 pm. Communications consultant and former health editor at The Sun, Jacqui Thornton, is presiding over proceedings as Judge. Experts giving evidence include Jenny Hope, medical correspondent at the Daily Mail, [...]
Posted on 08. Apr, 2010 by Ze Frollein.
We are inviting all industry communications and marketing executives, medics and signatories to attend our exclusive evening event at Brown’s Court house in central London on Wednesday 21 April 2010 from 18:30 – 19:45. We will hear from our high-profile journalist jury about what compelling media materials look like and how to make them both [...]
Posted on 22. Mar, 2010 by Handbaglady.
The USA moved one step closer this week to healthcare for all, (despite no Republican support(!) with the approval of President Obama’s 10 year health reform bill. This is fantastic news for the estimated 32 million uninsured Americans and also for Obama himself but what does this mean for the pharmaceutical industry as a whole? [...]
Posted on 18. Mar, 2010 by Claire.
I recently read the excellent and enlightening HCA report ‘Five Years of Change in Healthcare Communications’. On first glance it appeared to paint a bleak picture of the way the healthcare communications industry is changing: Stricter regulations are making our business more challenging in terms of creativity and meeting business objectives; agencies are having to [...]